By printing and/or reading this article, you agree that you accept all terms and conditions of use, as specified online.

Generic Drug Approved for Dementia

In the news...(December 18, 2009) - The Food and Drug Administration (FDA) has given the approval for the first generic version of Aricept (donepezil hydrochloride) orally disintegrating tablet. Donepezil hydrochloride is used for the treatment of dementia related to Alzheimer's disease. (Read about "Dementia" "Alzheimer's Disease")

Orally disintegrating tablets dissolve on the tongue, without having to be swallowed whole. This may make it easier to take the medication for older or disabled patients who have difficulty swallowing.

Alzheimer's disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with Alzheimer's disease, symptoms first appear after age 60. Alzheimer's disease is the most common cause of dementia among older people, but it is not a normal part of aging.

Dementia refers to a decline in cognitive function that interferes with daily life and activities. Alzheimer's disease starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain.

The generic donepezil hydrochloride orally disintegrating tablets have been approved in 5 milligram and 10 mg strengths.

Note: Statements and conclusions of study authors that are published here are solely those of the study authors and do not necessarily reflect this hospital's policy or position. This hospital makes no representation or warranty as to their accuracy or reliability.

All Concept Communications material is provided for information only and is neither advice nor a substitute for proper medical care. Consult a qualified healthcare professional who understands your particular history for individual concerns.

© Concept Communications Media Group LLC

Online health topics reviewed/modified in 2009 | Terms of Use/Privacy Policy

By printing and/or reading this article, you agree that you accept all terms and conditions of use, as specified online.